S. Urata

Clinical Features and Treatment Outcomes of Hematopoietic Stem Cell Transplantation During 2006-2016 at a Single Institution in Miyazaki Prefecture

K. Akashi, T. Miyamoto, Y. Mori, 2019, Journal of Hematopoietic Cell Transplantation.

JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

K. Akashi, K. Takenaka, T. Miyamoto, 2010, British journal of haematology.

The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.

K. Akashi, H. Iwasaki, K. Takenaka, 2014, Experimental hematology.

Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.

K. Akashi, H. Iwasaki, K. Takenaka, 2013, Blood.

Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era

K. Akashi, H. Iwasaki, K. Takenaka, 2012, American journal of hematology.

Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography in relapsed and refractory aggressive lymphoma

S. Baba, K. Akashi, K. Takenaka, 2022, International Journal of Hematology.

Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography in relapsed and refractory aggressive lymphoma

S. Baba, K. Akashi, K. Takenaka, 2022, International Journal of Hematology.

Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.

K. Akashi, T. Miyamoto, Y. Mori, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

K. Akashi, H. Iwasaki, K. Takenaka, 2011, Cancer cell.

TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.

K. Akashi, H. Iwasaki, K. Takenaka, 2010, Cell Stem Cell.

Outcomes of methotrexate‐associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease‐modifying anti‐rheumatic drugs

K. Akashi, H. Iwasaki, H. Asaoku, 2021, British journal of haematology.

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

K. Akashi, H. Iwasaki, K. Takenaka, 2011, Cancer cell.